PHARMACIE PHARMABELLE : revenue, balance sheet and financial ratios

PHARMACIE PHARMABELLE is a French company founded 13 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MONTVALEZAN (73700), this company of category PME shows in 2017 a revenue of 481 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE PHARMABELLE (SIREN 752503193)
Indicator 2024 2023 2022 2017 2016
Revenue N/C N/C N/C 480 954 € 460 811 €
Net income 0 € 0 € 0 € 40 844 € 20 714 €
EBITDA N/C N/C N/C 59 980 € 31 135 €
Net margin N/C N/C N/C 8.5% 4.5%

Revenue and income statement

In 2024, PHARMACIE PHARMABELLE records a net loss of 0 €. This deficit will reduce equity on the balance sheet. Change over 2016-2017: 21 k€ -> 0 €.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 71%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

70.952%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

38.66%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

30.9%

Solvency indicators evolution
PHARMACIE PHARMABELLE

Sector positioning

Debt ratio
70.95 2024
2022
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average

In 2024, the debt ratio of PHARMACIE PHARMABELLE (70.95) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
38.66% 2024
2022
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Average

In 2024, the financial autonomy of PHARMACIE PHARMABELLE (38.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 209.09. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

209.091

Liquidity indicators evolution
PHARMACIE PHARMABELLE

Sector positioning

Liquidity ratio
209.09 2024
2022
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Good +29 pts over 3 years

In 2024, the liquidity ratio of PHARMACIE PHARMABELLE (209.09) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE PHARMABELLE

Positioning of PHARMACIE PHARMABELLE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE PHARMABELLE with other companies in the same sector:

Frequently asked questions about PHARMACIE PHARMABELLE

What is the revenue of PHARMACIE PHARMABELLE ?

The revenue of PHARMACIE PHARMABELLE in 2017 is 481 k€.

Is PHARMACIE PHARMABELLE profitable?

Yes, PHARMACIE PHARMABELLE generated a net profit of 41 k€ in 2017.

Where is the headquarters of PHARMACIE PHARMABELLE ?

The headquarters of PHARMACIE PHARMABELLE is located in MONTVALEZAN (73700), in the department Savoie.

Where to find the tax return of PHARMACIE PHARMABELLE ?

The tax return of PHARMACIE PHARMABELLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE PHARMABELLE operate?

PHARMACIE PHARMABELLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.